2009.04.30 Weekly Broadcast Email
There were no updates made the website for the week of April 27, 2009.
98308 (A Phase III Randomized, Double-Blind, Placebo Controlled Trial of North American Ginseng Extract (CVT-E002; COLD-fX®) to
Prevent Respiratory Infection and Reduce Antibiotic Use in Patients with Chronic Lymphocytic Leukemia)
Lab shippers and air bills will sent to sites soon. Sites should use these shippers to send specimens to the WFU lab. If you have questions, please contact Abbie Beltz at (336) 716-9134 or email@example.com.
Please note: There are some sites that have not yet submitted an invoice for the $650 per patient reimbursement associated with this study. With our fiscal year coming to a close, we need to have those invoices submitted to us within the next two weeks. If you have any questions please contact firstname.lastname@example.org
91105 (Phase III Double Blind, Placebo Controlled Study of Donepezil in Irradiated Brain Tumor Patients)
Sites should contact Robin Rosdhal at (336) 713-6519 or Rosdhal@wfubmc.edu to request patient gift cards.
97405 (Randomized Study of Soy Protein and Effexor on Vasomotor Symptoms of Men with Prostate Cancer)
Since the closure of the COLD-fX, is your site looking for a new study? Then consider enrolling patients in the Soy/Effexor trial.
Our goal is to have 125 patients registered by June 1st. Click here to download the protocol documents, view slide show presentations, and more. Consider joining the Research Base in reaching its June 1st goal!